Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Update Il y a 4 ans
Reference: NCT00967993

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a dietary phosphate binder in controlling and managing serum phosphorus levels in patients with end-stage renal disease (ESRD).


Inclusion criteria

  • Hyperphosphatemia,End stage renal disease,Renal Failure Chronic Requiring Hemodialysis

Links